CIK: 0001082621 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Feb 8, 2019
Total Value ($000): $474,590 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AAPL | APPLE INC | 1,040,895 | $164,191 | 34.6% | $45.43 | +1.3% | COM | 037833100 |
| MSFT | MICROSOFT CORP | 1,128,047 | $114,576 | 24.1% | $87.74 | +14.0% | COM | 594918104 |
| GOOGL | ALPHABET INC | 62,202 | $64,999 | 13.7% | $54.33 | -1.3% | CAP STK CL A | 02079K305 |
| META | FACEBOOK INC | 376,996 | $49,420 | 10.4% | $175.16 | -17.9% | CL A | 30303M102 |
| IVV | ISHARES TR | 77,028 | $19,381 | 4.1% | $169.98 | — | CORE S&P500 ETF | 464287200 |
| VEA | VANGUARD TAX MANAGED INTL FD | 329,391 | $12,220 | 2.6% | $35.82 | — | FTSE DEV MKT ETF | 921943858 |
| GLD | SPDR GOLD TRUST | 100,044 | $12,136 | 2.6% | $118.13 | — | GOLD SHS | 78463V107 |
| VWO | VANGUARD INTL EQUITY INDEX F | 190,743 | $7,267 | 1.5% | $46.12 | — | FTSE EMR MKT ETF | 922042858 |
| QQQ | INVESCO QQQ TR | 45,909 | $7,082 | 1.5% | $172.05 | — | UNIT SER 1 | 46090E103 |
| EDV | VANGUARD WORLD FD | 47,205 | $5,356 | 1.1% | $114.12 | — | EXTENDED DUR | 921910709 |
| IJH | ISHARES TR | 27,157 | $4,510 | 1.0% | $124.12 | — | CORE S&P MCP ETF | 464287507 |
| IJR | ISHARES TR | 58,524 | $4,057 | 0.9% | $69.16 | — | CORE S&P SCP ETF | 464287804 |
| — | NEON THERAPEUTICS INC | 505,871 | $2,545 | 0.5% | $12.60 | — | COM | 64050Y100 |
| — | MAGENTA THERAPEUTICS INC | 411,379 | $2,345 | 0.5% | $12.01 | — | COM | 55910K108 |
| VIG | VANGUARD GROUP | 19,560 | $1,916 | 0.4% | $66.20 | — | DIV APP ETF | 921908844 |
| — | ADURO BIOTECH INC | 640,595 | $1,691 | 0.4% | $10.65 | — | COM | 00739L101 |
| TROW | T ROWE PRICE GROUP INC | 9,731 | $898 | 0.2% | $73.13 | 0.0% | COM | 74144T108 |